Clinical Trial Update: Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803

View source ↗

Summary

The document reports on the completion of the ECOG-E5803 study, which collected tissue and blood samples from patients with recurrent prostate cancer who were t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Prostate Cancer | Status: COMPLETED